Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


How Can Primary Care Providers Help Their Patients Decide if PrEP Is Right for Them?
Kenneth Mayer, MD, explains why primary care providers need to have a good sense of their patients in order to help them decide if PrEP is right for them.
Preventing Candida auris Infections in At-Risk Patients
Snigdha Vallabhaneni, MD, MPH, shares actions patients and their visitors can take to protect themselves from Candida auris.
New Formulation of Raltegravir HD Explained
Pedro Cahn, MD, explains the new formulation of raltegravir HD.
What is the LATTE-2 Trial for HIV Treatment?
Peter Williams, PhD, discusses the LATTE-2 trial for HIV treatment.
What Makes a Biomedical Implant a Desirable Way to Administer PrEP?
Ariane van der Straten, PhD, MPH, explains the different attributes of administering pre-exposure prophylaxis via a HIV biomedical implant.
Tenofovir Alafenamide: The Future of Pre-Exposure Prophylaxis?
Kenneth Mayer, MD, explains why tenofovir alafenamide may be the future of pre-exposure prophylaxis.
Importance of Surgical Teams Voicing Safety Concerns in Operating Rooms
Arjun Srinivasan, MD, stresses the importance of surgical teams speaking up if they have safety concerns regarding procedure in operating rooms.
Investigating <i>Pseudomonas</i> Susceptibility to Ceftolozane/tazobactam
Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.
We break down our top HIV news stories of 2017. Did you read them all?